Marchitelli, Rocco https://orcid.org/0000-0003-1994-2332
Paillère Martinot, Marie-Laure
Trouvé, Alain
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta https://orcid.org/0000-0003-4809-5398
Garavan, Hugh
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Papadopoulos Orfanos, Dimitri https://orcid.org/0000-0002-1242-8990
Paus, Tomáš
Poustka, Luise
Hohmann, Sarah
Holz, Nathalie
Vaidya, Nilakshi https://orcid.org/0000-0002-4600-7158
Fröhner, Juliane H.
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Schumann, Gunter
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Artiges, Eric https://orcid.org/0000-0003-4461-7646
,
Article History
Received: 19 July 2023
Revised: 3 May 2024
Accepted: 13 May 2024
First Online: 2 July 2024
Competing interests
: TB served in an advisory or consultancy role for ADHS Digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Medice and Takeda. He has been involved in clinical trials conducted by Shire & Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. He has been involved in clinical trials conducted by Shire & Viforpharma. GB has received honoraria from General Electric Healthcare for teaching on scanner programming courses. LP served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe, Kohlhammer, and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical commercial relationships or conflicts of interest.